Cefiderocol-associated brown chromaturia.

BMJ Case Rep

Tufts Medical Center, Boston, Massachusetts, USA

Published: December 2023

Cefiderocol is a novel siderophore cephalosporin antibiotic. In the present case report, a woman in her 70s presented with a 1-week history of altered mental status and progressive purulent discharge from a non-healing diabetic foot ulcer on her right heel. MRI of the right foot revealed chronic osteomyelitis of the calcaneum. Surgical debridement was performed, and the tissue cultures grew extensively drug resistant (XDR) , XDR and The patient received ampicillin-sulbactam and cefiderocol. The antibiotic treatment course was complicated by brown urine discolouration. Investigations were unrevealing for haemoglobinuria, myoglobinuria and bilirubinuria. A side effect from cefiderocol was suspected and subsequently discontinued. Her urine colour returned to its normal colour within 3 days of discontinuation of cefiderocol.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10728909PMC
http://dx.doi.org/10.1136/bcr-2023-258207DOI Listing

Publication Analysis

Top Keywords

cefiderocol-associated brown
4
brown chromaturia
4
cefiderocol
4
chromaturia cefiderocol
4
cefiderocol novel
4
novel siderophore
4
siderophore cephalosporin
4
cephalosporin antibiotic
4
antibiotic case
4
case report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!